US continues push for public access to science

By Staff Writers
Friday, 16 April, 2010

Fuelling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the US House of Representatives by Republican Mike Doyle (D-PA) and a bi-partisan host of co-sponsors.

The proposed bill would build on the success of the first US mandate for public access to the published results of publicly funded research at the National Institutes of Health (NIH), and require federal agencies with annual extramural research budgets of $100 million or more to provide the public with online access to research manuscripts stemming from funded research no later than six months after publication in a peer-reviewed journal.

Like the Senate bill introduced in 2009 by Senators Lieberman and Cornyn, H.R. 5037 would unlock unclassified research funded by agencies including the Department of Agriculture, Department of Commerce, Department of Defense, Department of Education, Department of Energy, Department of Health and Human Services, Department of Homeland Security, Department of Transportation, Environmental Protection Agency, National Aeronautics and Space Administration and the National Science Foundation.

H.R. 5037 follows closely on the heels of a recent expression of interest in public access policies from the White House Office of Science and Technology Policy, which issued a request for public comment on mechanisms that would leverage federal investments in scientific research and increase access to information that promises to stimulate scientific and technological innovation and competitiveness.

Related News

AusBiotech and Proto Axiom partner on investor-focused life sciences programs

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

The University of Sydney formalises cervical cancer elimination partnership

The success of a cervical cancer elimination program has led to the signing of a memorandum of...

Noxopharm says paper reveals science behind its immune system platform

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd